YUM
33
-2
ALLE
19
3
FOXA
67
-2
PEP
32
2
R
55
3
NEE
41
2
XRAY
28
3
CLX
68
2
ED
45
3
UNP
38
2
AIG
32
-3
EBAY
62
12
LYB
34
-2
KMI
79
2
HAL
36
-7
STT
59
14
AA
38
-2
CTAS
49
4
MMM
47
2
JCI
45
4
YUM
33
-2
ALLE
19
3
FOXA
67
-2
PEP
32
2
R
55
3
NEE
41
2
XRAY
28
3
CLX
68
2
ED
45
3
UNP
38
2
AIG
32
-3
EBAY
62
12
LYB
34
-2
KMI
79
2
HAL
36
-7
STT
59
14
AA
38
-2
CTAS
49
4
MMM
47
2
JCI
45
4
Financhill
Back

Vanguard Canadian Short-Term Corporate Bd Idx ETF Vs. Janux Therapeutics Industry Stock Comparison

Sell
42

VSC.TO
Vanguard Canadian Short-Term Corporate Bd Idx ETF

Last Price:
$24.06
Seasonality Move:
-0.39%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
42
Vanguard Canadian Short-Term Corporate Bd Idx ETF (VSC.TO) is a Sell

Is Vanguard Canadian Short-Term Corporate Bd Idx ETF a Buy, Sell or Hold?

  • The current Vanguard Canadian Short-Term Corporate Bd Idx ETF [VSC.TO] share price is $24.06. The Score for VSC.TO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • VSC.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VSC.TO Stock Price Chart

What is Vanguard Canadian Short-Term Corporate Bd Idx ETF's stock price today?

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

VSC.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 52.96 Buy
Chaikin Money Flow: 11377 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.02 - 24.1) Sell
Bollinger Bands (100): (23.89 - 24.07) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

VSC.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.07 Sell
20-day SMA: 24.07 Sell
50-day SMA: 24 Buy
200-day SMA: 23.7 Buy
8-day EMA: 24.06 Sell
20-day EMA: 24.05 Buy
50-day EMA: 24.01 Buy
200-day EMA: 23.73 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Vanguard Canadian Short-Term Corporate Bd Idx ETF Earnings Growth & VSC.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Vanguard Canadian Short-Term Corporate Bd Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):